Caplight Directory>Companies>Encodia-preview>Encodia


Encodia

Encodia

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.encodia.com

Last Round

Grant

May 1, 2021

Total Funding Raised

$75.7M

Company Overview

Encodia is a biotechnology company that offers a protein analysis software platform utilizing innovative reverse-translation technology to democratize protein sequencing and provide comprehensive proteome information for researchers.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

scalable proteomicsproteomicsnext-generation proteomicsprotein sequencingProteoCode PlatformNGS-based proteomicsreverse-translation technologyproteogenomicsnext-generation sequencingNGSdrug discoverybiomarker discoverylife science toolsbenchtop instrumentmass spectrometry alternativerazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Encodia Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Encodia Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2021
Series CJan 27, 2021
GrantSep 13, 2018
GrantSep 1, 2016
View all Funding Rounds

Encodia Investors

Notable investors and investment history

InvestorRounds
Deerfield ManagementSeries C
National Cancer InstituteGrant
GVSeries C
NIH RADxGrant
Nan Fung Life SciencesSeries C
Decheng CapitalSeries C
Biomatics Capital PartnersSeries C
View all Investors

Encodia Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Encodia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Encodia's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range24
Year Founded2015
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.